The growing epidemic of obesity starkly highlights the urgency in addressing this health crisis, particularly among infants, children, and adolescents.

Obesity is a chronic disease with many contributing factors, including family history, access to healthy foods, hormonal and metabolic conditions and even environmental factors such as how “walkable” ...

Addressing obesity is not a one-size-fits-all approach, Dr. Sam Wilcox told a capacity Lunch & Learn crowd in Iola Wednesday.

Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will feature two oral presentations, one poster presentation, and chair ...

Anand Mahindra underlines the need for a healthier population to achieve India’s 2047 vision, responding to PM Modi’s call to reduce oil consumption. Notable figures like R. Madhavan and Nandan ...

Allowing such medications as options could lead to significant savings from improved health, writes Kelley Koch.

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

To prevent obesity, you need to stay active, follow a healthy diet, and get adequate sleep. Obesity prevention also involves saying no to certain preferences, like soft drinks, or driving short ...

In fact, childhood obesity has become so alarmingly prevalent and such a threat to children’s health that the American Academy of Pediatrics (AAP) has an entire website dedicated to its prevention and ...

Marvel dropped posters for a forthcoming film and one sparked quite a response. “The Fantastic Four: First Steps” tells the story of Marvel’s first family and stars Pedro Pascal as Reed ...

Sales of Novo Nordisk’s obesity drugs, such as Wegovy, rose by more than 50 per cent last year, helping send shares in Europe’s most valuable listed company almost 5 per cent higher.

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed ...